Novel smoothened antagonists as anti‐neoplastic agents for the treatment of osteosarcoma
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cellular Physiology"
DOI: 10.1002/jcp.26330
Abstract: Osteosarcoma (OS) is an ultra‐rare highly malignant tumor of the skeletal system affecting mainly children and young adults and it is characterized by an extremely aggressive clinical course. OS patients are currently treated with chemotherapy… read more here.
Keywords: smoothened antagonists; treatment; antagonists anti; anti neoplastic ... See more keywords